Tipranavir in highly antiretroviral treatment-experienced patients: Results from a French prospective cohort-Reference-Cited by-同舟云学术

Tipranavir in highly antiretroviral treatment-experienced patients: Results from a French prospective cohort

Published:2011-08-19 Issue:1 Volume:44 Page:37-43
ISSN:0036-5548
Container-title:Scandinavian Journal of Infectious Diseases
language:en
Short-container-title:Scandinavian Journal of Infectious Diseases

Author:

Allavena Clotilde,Flandre Philippe,Pugliese Pascal,Valantin Marc-Antoine,Poizot-Martin Isabelle,Cabié André,Melliez Hugues,Cuzin Lise,Duvivier Claudine,Dellamonica Pierre,Raffi François,

Publisher

Informa UK Limited

Subject

Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/00365548.2011.598870

Reference25 articles.

1. Durable efficacy of tipranavir-ritonavir in combination with an optimised background regimen of antiretroviral drugs for treatment-experienced HIV-1-infected patients at 48 weeks in the Randomized Evaluation of Strategic Intervention in multi-drug reSistant patients with Tipranavir (RESIST) studies: an analysis of combined data from two randomised open-label trials

2. Long-Term Efficacy and Safety of Tipranavir Boosted With Ritonavir in HIV-1-Infected Patients Failing Multiple Protease Inhibitor Regimens

3. Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials

4. Predicting Tipranavir and Darunavir Resistance Using Genotypic, Phenotypic, and Virtual Phenotypic Resistance Patterns: an Independent Cohort Analysis of Clinical Isolates Highly Resistant to All Other Protease Inhibitors

5. Efficacy and safety of once-daily darunavir/ritonavir versus lopinavir/ritonavir in treatment-naive HIV-1-infected patients at week 48

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Highly multidrug-resistant HIV: clonal analysis and therapeutic strategies;Journal of Antimicrobial Chemotherapy;2013-07-19

2. The Nucleoside Reverse Transcriptase Inhibitors, Nonnucleoside Reverse Transcriptase Inhibitors, and Protease Inhibitors in the Treatment of HIV Infections (AIDS);Antiviral Agents;2013